Improving person-centred care for people with dementia in care homes
| ISRCTN | ISRCTN40313497 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN40313497 |
| ClinicalTrials.gov number | NCT01855152 |
| Secondary identifying numbers | RP-PG-0608-10133 |
- Submission date
- 07/02/2011
- Registration date
- 10/05/2011
- Last edited
- 06/09/2019
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Plain English summary of protocol
Background and study aims
250,000 people with dementia in the UK live in care homes. These individuals have complex mental health problems, disabilities and social needs, which are made worse by widespread prescription of sedative drugs. The inconsistent quality of care, the poor management of mental health problems and the widespread overuse of sedative drugs are matters for serious concern. The launch of the National Dementia Strategy (2009) and a parallel Department of Health report (2009) regarding the use of sedative drugs provides an opportunity to move forward on a national basis to provide a better trained workforce that can improve the mental health of people with dementia living in care homes and reduce the use of sedative drugs.
The main goal of the WHELD programme is to develop an effective, simple and practical programme (intervention), which improves the mental health of, and reduces sedative drug use in, people with dementia in care homes; which can be rolled out nationally. This study will determine the most effective elements of existing approaches. This will be achieved by training care staff to provide care that is focused on an understanding of the individual and their needs; and by using additional elements such as exercise, activities and social interaction to improve mental health, reduce the use of sedative drugs and improve quality of life. The interventions studied will be Person Centred Care training either alone or in combination with Antipsychotic Review, Exercise and Social Interaction.
The main aim of the study is to determine whether the combination of Person Centred Care and Antipsychotic Review results in the reduction of antipsychotic prescribing and improvement of participant outcomes compared to Person Centred Care training alone.
The secondary objective is to establish the specific impact of each therapy (Antipsychotic Review, Social Intervention and Pleasant Activities, Exercise) in addition to Person Centred Care training on a range of outcomes including: mental health; psychotropic drug use; physical health; and quality of life. We also aim to determine the impact on potentially important mediating factors such as: activities; social interactions; staff attitudes; and the quality of the interaction between care staff and people with dementia.
The findings from this study will be used to develop the programme further for a larger study.
Who can participate?
All individuals with dementia living in the care homes participating in the study, aged between 40 and 120 years, will be invited to participate. Individuals for whom consent has not been obtained will not be included in the study.
What does the study involve?
This study will be conducted in 16 care homes recruited into the study across Oxfordshire, Buckinghamshire, North & South London. A minimum of 12 participants from each care home will be recruited into the study. Data will be collected on all consenting residents who meet the inclusion criteria at each participating care home. Each care home will receive a randomly allocated intervention for 9 months. Evaluations will be undertaken to understand the breadth of benefits conferred by the 3 key interventions to be assessed when used in addition to the Person Centred Care training package, which has already been shown to work. The interventions involve the following:
Person Centred Care: This intervention uses best practice guidelines to improve care. It provides ways of reviewing and adapting individual residents care to ensure that it reflects their needs and choices and includes elements of leadership training and approaches that address common team concerns about change.
Antipsychotic Review: This involves a specific review of antipsychotic drugs based on expert opinion and guidelines. Ideas for assessment and alternative approaches are also included.
Social Interaction: This intervention aims to develop skills and techniques amongst the care team for delivering individual and group activities to enhance interactions between staff and residents.
Exercise: This intervention aims to promote exercise through encouraging enjoyable positive activities that involve exercise, through implementing exercise plans, which are realistic and appropriate to residents level of dementia, and designed to increase balance, strength, endurance and flexibility.
What are the possible benefits and risks of participating?
Participants will receive benefits as a result of training of care staff. There are minimal risks or burdens for participants.
Where is the study run from?
Oxford Health NHS Foundation Trust and Kings College London.
When is the study starting and how long is it expected to run for?
The study started in August 2011 and ended in November 2012, running for 16 months
Who is funding the study?
National Institute for Health Research (NIHR)
Who is the main contact?
Professor Clive Ballard, Wolfson Centre for Age Related Diseases, Kings College London
Contact information
Scientific
Kings College London
Guy's Campus
London
SE1 1UL
United Kingdom
Study information
| Study design | Cluster randomised 2 x 2 x 2 factorial pilot study |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Quality of life |
| Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
| Scientific title | An optimised person-centred intervention to improve mental health and reduce anti-psychotics amongst people with dementia in care homes |
| Study acronym | WHELD |
| Study objectives | The overarching goal of the programme is to provide an effective, simple and practical intervention, which improves the mental health and reduces sedative drugs in people with dementia in care homes, and which can be rolled out nationally to all UK care homes as an National Health Service (NHS) intervention. The current study is the pilot study and qualitative evaluation to help to develop a larger randomised controlled clinical trial, which will establish the value of (Well-being and health for people with dementia) WHELD. We hypothesise that each intervention will significantly improve several key outcomes, but none of the interventions will improve all outcomes on their own. This pilot study is not powered to answer these questions definitively. The role of these hypotheses are to guide the analysis and to generate firm hypotheses for testing in the main trial. Specifically we hypothesise that, compared to person-centred care alone: 1. The combination of person-centred care and antipsychotic review will result in the reduction of antipsychotic prescribing 2. The combination of person-centred care and social interaction will result in additional improvements in agitation/aggression, especially in individuals already experiencing these symptoms at the baseline evaluation 3. The combination of person-centred care and exercise will improve the overall mood and will reduce the number of falls Please note that as of 21/01/2013, the following changes were made to the record: 1. The anticipated start date for this trial was updated from 03/05/2011 to 03/08/2011 2. The anticipated end date for this trial was updated from 03/02/2012 to 09/11/2012 |
| Ethics approval(s) | Approval pending as of 10/05/2011 |
| Health condition(s) or problem(s) studied | Dementia |
| Intervention | Evaluations will be undertaken to understand the breadth of benefits conferred by three key interventions to be assessed when used in addition to the person-centred care (PCC) training package, whose efficacy has already been established: 1. Person-centred care (PCC): PCC training will be delivered using the operationalised FITS manual. This will be further augmented by additional elements of leadership training on the basis of input from an expert therapy development group. 2. Antipsychotic review: This will involve specific review of antipsychotic drugs by an expert clinician, based upon the principles outlined in the National Institute for Health and Clinical Excellence (NICE) dementia guidelines. In addition, for all participants continuing to receive antipsychotics after the initial review or where antipsychotics are started or re-started, a detailed medical antipsychotic care plan will be developed. This will include planned dates for further antipsychotic review. 3. Social Intervention and Pleasant Activities: An intervention manual will be developed based upon three evidence based approaches and specific communication skills training to enhance staff resident interactions. The approaches will include: 3.1. The Positive Events Schedule, developed and demonstrated to be effective in the treatment of agitation and depression in people with dementia in non-care home settings 3.2. The Social Interaction intervention demonstrated to be effective for the treatment of agitation in people with dementia in care homes 3.3. The NEST programme Minor adaptations will be undertaken, in collaboration with the authors who developed the manuals, to ensure that they are suitable and practical for administration in a UK care home setting. 4. Exercise: The main focus will be to promote exercise through encouraging enjoyable positive activities that involve exercise. People will be offered enjoyable individual and group exercise activities to augment activities identified specifically as hobbies or enjoyable activities by individual participants. Please note that this trial is co-sponsored; the contact details for the co-sponsor are as follows: Oxford Health NHS Foundation Trust c/o Jane Fossey Clinical Head of Psychological Services Chancellor Court 4000 John Smith Drive Oxford Business Park South Oxford OX4 2GX T: +44 (0)18 6573 8445 E: jane.fossey@obmh.nhs.uk Website: http://www.obmh.nhs.uk |
| Intervention type | Other |
| Primary outcome measure | 1. Antipsychotic use (number and proportion of people and dose) - measured at baseline and post intervention using records search and drug chart 2. Agitation - measured at baseline and post intervention using the Cohen-Mansfield Agitation Inventory |
| Secondary outcome measures | 1. Use of psychotropic drugs (number and proportion of people and dose) - measured at baseline and post intervention using records search and drug chart 2. Other (not including agitation) behavioural and neuropsychiatric symptoms including apathy and psychosis - measured at baseline and post intervention using the NeuroPsychiatric Inventory - Nursing Home version (NPI NH) 3. Mood - measured at baseline and post intervention using the Cornell Depression Scale 4. Unmet Needs - measured at baseline and post intervention using theCamberwell Assessment of Need in the Elderly (CANE) 5. Quality of Life - measured at baseline and post intervention using a measure of health-related quality of life for people with dementia (DEMQOL) and Quality Of Life in Alzheimer's Disease (QoL AD) 6. Quality of interactions between staff and residents - measured at baseline and post intervention using the Quality of Interaction Scale (QUIS) 7. Falls - measured on an on-going basis using falls records |
| Overall study start date | 03/08/2011 |
| Completion date | 09/11/2012 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Senior |
| Sex | Both |
| Target number of participants | 16 suitable homes will be identified, recruited, randomised and the intervention delivered to all residents. |
| Key inclusion criteria | Current inclusion criteria as of 21/01/2013: All individuals residing in participating care homes who score 1 or greater on the CDR and score 4 or greater on the FAST in the 16 participating care facilities will be eligible to participate. Previous inclusion criteria until 21/01/2013: All individuals (aged 40 - 120 years, either sex) with dementia residing [ Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM IV) criteria, FAST staging] in the 16 participating care facilities will be eligible to participate |
| Key exclusion criteria | Absence of dementia. Data will not be collected from individuals for whom consent has not been obtained. |
| Date of first enrolment | 03/08/2011 |
| Date of final enrolment | 09/11/2012 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
SE1 1UL
United Kingdom
Sponsor information
University/education
c/o Professor Clive Ballard
Professor of Age Related Diseases
The Strand
London
WC2 2LS
England
United Kingdom
| Website | http://www.kcl.ac.uk |
|---|---|
"ROR" |
https://ror.org/0220mzb33 |
Funders
Funder type
Government
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol article | protocol | 10/01/2013 | Yes | No | |
| Results article | results | 06/02/2018 | 06/09/2019 | Yes | No |
Editorial Notes
06/09/2019: This is a duplicate of ISRCTN62237498.
The following changes were made to the trial record:
1. ClinicalTrials.gov number added.
2. Publication reference added.
30/08/2018: Internal review.
